Global Incidence and Mortality of Gastric Cancer, 1980-2018

Martin C S Wong, Junjie Huang, Paul S F Chan, Peter Choi, Xiang Qian Lao, Shannon Melissa Chan, Anthony Teoh, Peter Liang, Martin C S Wong, Junjie Huang, Paul S F Chan, Peter Choi, Xiang Qian Lao, Shannon Melissa Chan, Anthony Teoh, Peter Liang

Abstract

Importance: Gastric cancer is one of the most common cancers, with a high mortality-to-incidence ratio. It is uncertain whether developed nations may encounter an increasing burden of gastric cancer in young adults, as occurs for other cancers.

Objectives: To evaluate the incidence and mortality of gastric cancer and compare the global incidence trends between younger (<40 years) and older (≥40 years) populations.

Design, setting, and participants: This population-based cohort study analyzed data from global and national cancer registries, including data from 1980 to 2018, with at least 15 calendar years of incidence and mortality data. Data on age-standardized incidence and mortality rates of gastric cancer among 48 countries were retrieved from the Surveillance, Epidemiology, and End Results Program, the National Cancer Institute, the Nordic Cancer Registries, and the World Health Organization Mortality Database. The 10-year incidence trend of gastric cancer was assessed by age and sex. The 2018 GLOBOCAN database was used for reporting the global incidence and mortality of gastric cancer, the most recent data available at the time of analysis. Analyses were performed between January 10, 2020, and March 20, 2020.

Main outcomes and measures: The average annual percent change (AAPC) of the incidence and mortality trends as evaluated by joinpoint regression analysis.

Results: A total of 1 033 701 new cases of gastric cancer and 782 685 related deaths were reported in 2018. Overall, the incidence of gastric cancer decreased in 29 countries, and mortality decreased in 41 countries. The age-standardized incidence of gastric cancer decreased from a range of 2.6 to 59.1 in 1980 to a range of 2.5 to 56.8 in 2018 per 100 000 persons. The overall age-standardized mortality rate changed from a range of 1.3 to 25.8 in 1980 to a range of 1.5 to 18.5 in 2018 per 100 000 persons, but increasing mortality was observed in Thailand (female: AAPC, 5.30; 95% CI, 4.38-6.23; P < .001; male: AAPC, 3.92; 95% CI, 2.14-5.74; P < .001). The incidence of gastric cancer decreased in most regions among individuals 40 years or older and increased in populations younger than 40 years in several countries, including Sweden (male: AAPC, 13.92; 95% CI, 7.16-21.11; P = .001), Ecuador (female: AAPC, 6.05; 95% CI, 1.40-10.92; P = .02), and the UK (male: AAPC, 4.27; 95% CI, 0.15-8.55; P = .04; female: AAPC, 3.60; 95% CI, 3.59-3.61; P < .001).

Conclusions and relevance: In this population-based cohort study, an increasing incidence of gastric cancer was observed in younger individuals in some countries, highlighting the need for more preventive strategies in younger populations. Future research should explore the reasons for these epidemiologic trends.

Conflict of interest statement

Conflict of Interest Disclosures: Dr Liang reported receiving grants from Epigenomics outside the submitted work. No other disclosures were reported.

Figures

Figure 1.. Global Incidence Rates of Gastric…
Figure 1.. Global Incidence Rates of Gastric Cancer
Data are from Bray et al. Reprinted with permission from Ferlay et al. ASR indicates age-standardized rate.
Figure 2.. Average Annual Percent Change (AAPC)…
Figure 2.. Average Annual Percent Change (AAPC) of the Incidence of Gastric Cancer in Individuals 40 Years or Older
Error bars indicate 95% CIs. NA indicates not available.
Figure 3.. Average Annual Percent Change (AAPC)…
Figure 3.. Average Annual Percent Change (AAPC) of the Incidence of Gastric Cancer in Individuals Younger Than 40 Years
Figure 4.. Average Annual Percent Change (AAPC)…
Figure 4.. Average Annual Percent Change (AAPC) of the Incidence of Gastric Cancer in Individuals 0 to 85 Years or Older
Error bars indicate 95% CIs.
Figure 5.. Average Annual Percent Change (AAPC)…
Figure 5.. Average Annual Percent Change (AAPC) of the Mortality of Gastric Cancer in Individuals 0 to 85 Years or Older
Error bars indicate 95% CIs. NA indicates not available.

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi:10.3322/caac.21492
    1. Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26-38. doi:10.5114/pg.2018.80001
    1. Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239-248. doi:10.2147/CMAR.S149619
    1. Luo G, Zhang Y, Guo P, Wang L, Huang Y, Li K. Global patterns and trends in stomach cancer incidence: age, period and birth cohort analysis. Int J Cancer. 2017;141(7):1333-1344. doi:10.1002/ijc.30835
    1. Ferlay J, Ervik M, Lam F, et al. . Global Cancer Observatory: cancer today. International Agency for Research on Cancer; 2020. Accessed November 10, 2020.
    1. Ahmed N. 23 Years of the discovery of Helicobacter pylori: is the debate over? Ann Clin Microbiol Antimicrob. 2005;4:17. doi:10.1186/1476-0711-4-17
    1. Hansson LE, Nyrén O, Hsing AW, et al. . The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 1996;335(4):242-249. doi:10.1056/NEJM199607253350404
    1. Wu AH, Tseng CC, Bernstein L. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer. 2003;98(5):940-948. doi:10.1002/cncr.11568
    1. Ye W, Chow WH, Lagergren J, Yin L, Nyrén O. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology. 2001;121(6):1286-1293. doi:10.1053/gast.2001.29569
    1. Ladeiras-Lopes R, Pereira AK, Nogueira A, et al. . Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2008;19(7):689-701. doi:10.1007/s10552-008-9132-y
    1. Fortunato L, Rushton L. Stomach cancer and occupational exposure to asbestos: a meta-analysis of occupational cohort studies. Br J Cancer. 2015;112(11):1805-1815. doi:10.1038/bjc.2014.599
    1. Tsugane S. Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci. 2005;96(1):1-6. doi:10.1111/j.1349-7006.2005.00006.x
    1. Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer. 2007;10(2):75-83. doi:10.1007/s10120-007-0420-0
    1. Liu H, Hua Y, Zheng X, et al. . Effect of coffee consumption on the risk of gastric cancer: a systematic review and meta-analysis of prospective cohort studies. PLoS One. 2015;10(5):e0128501. doi:10.1371/journal.pone.0128501
    1. Tramacere I, Negri E, Pelucchi C, et al. . A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol. 2012;23(1):28-36. doi:10.1093/annonc/mdr135
    1. Takeno S, Hashimoto T, Maki K, et al. . Gastric cancer arising from the remnant stomach after distal gastrectomy: a review. World J Gastroenterol. 2014;20(38):13734-13740. doi:10.3748/wjg.v20.i38.13734
    1. Henderson TO, Oeffinger KC, Whitton J, et al. . Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study. Ann Intern Med. 2012;156(11):757-766, W-260. doi:10.7326/0003-4819-156-11-201206050-00002
    1. Singh S, Jha HC. Status of Epstein-Barr virus coinfection with Helicobacter pylori in gastric cancer. J Oncol. 2017;2017:3456264. doi:10.1155/2017/3456264
    1. World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) . Continuous Update Project Report: Diet, Nutrition, Physical Activity and Stomach Cancer 2016. Revised 2018. World Cancer Research Fund International; 2018.
    1. GBD 2017 Stomach Cancer Collaborators. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):42-54. doi:10.1016/S2468-1253(19)30328-0
    1. Wong MC, Huang J, Lok V, et al. . Differences in incidence and mortality trends of colorectal cancer, worldwide, based on sex, age, and anatomic location. Clin Gastroenterol Hepatol. 2021;19(5):955-966.e61. doi:10.1016/j.cgh.2020.02.026
    1. Li J. Gastric cancer in young adults: a different clinical entity from carcinogenesis to prognosis. Gastroenterol Res Pract. 2020;2020:9512707. doi:10.1155/2020/9512707
    1. Smith AW, Bellizzi KM, Keegan TH, et al. Health-related quality of life of adolescent and young adult patients with cancer in the United States: the Adolescent and Young Adult Health Outcomes and Patient Experience study. J Clin Oncol. 2013;31(17):2136–2145. doi:10.1200/JCO.2012.47.3173
    1. United Nations Development Programme. Human Development Report 2013: the rise of the South: human progress in a diverse world. 2013. Accessed March 20, 2021.
    1. Bray F, Colombet M, Mery L, et al. Cancer Incidence in Five Continents. Vol XI. International Agency for Research on Cancer; 2017.
    1. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program. Surveillance, Epidemiology, and End Results (SEER) Program: populations (1969-2016). 2017. Accessed March 20, 2021.
    1. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program. Quality improvement process. 2019. Accessed March 20, 2021.
    1. Engholm G, Ferlay J, Christensen N, et al. . Cancer incidence, mortality, prevalence and survival in the Nordic countries. Version 8.1 (28.06.2018). Association of the Nordic Cancer Registries. Danish Cancer Society; 2018. Accessed March 20, 2021.
    1. Engholm G, Ferlay J, Christensen N, et al. . NORDCAN: a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49(5):725-736. doi:10.3109/02841861003782017
    1. International Agency for Research on Cancer. Cancer Incidence in Five Continents. Vol XI. 2018. Accessed March 15, 2021.
    1. World Health Organization . International Classification of Diseases for Oncology, Third Edition. World Health Organization, 2013.
    1. Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ. 2005;83(3):171-177.
    1. Segi M, Fujisaku S, Kurihara M. Geographical observation on cancer mortality by selected sites on the basis of standardised death rate. Gan. 1957;48(2):219-225.
    1. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335-351. doi:10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>;2-Z
    1. Wong MC, Goggins WB, Wang HH, et al. . Global incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries. Eur Urol. 2016;70(5):862-874. doi:10.1016/j.eururo.2016.05.043
    1. Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med. 2009;28(29):3670-3682. doi:10.1002/sim.3733
    1. Global Cancer Observatory . GLOBOCAN 2018. Updated December 2020. Accessed November 10, 2020.
    1. Ang TL, Fock KM. Clinical epidemiology of gastric cancer. Singapore Med J. 2014;55(12):621-628. doi:10.11622/smedj.2014174
    1. World Health Organization . Schistosomes, liver flukes and Helicobacter pylori: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1-241.
    1. Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015;136(2):487-490. doi:10.1002/ijc.28999
    1. Yim JY, Kim N, Choi SH, et al. . Seroprevalence of Helicobacter pylori in South Korea. Helicobacter. 2007;12(4):333-340. doi:10.1111/j.1523-5378.2007.00504.x
    1. Wang KJ, Wang RT. Meta-analysis on the epidemiology of Helicobacter pylori infection in China [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2003;24(6):443-446.
    1. Fujisawa T, Kumagai T, Akamatsu T, Kiyosawa K, Matsunaga Y. Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan. Am J Gastroenterol. 1999;94(8):2094-2099. doi:10.1111/j.1572-0241.1999.01283.x
    1. Mbulaiteye SM, Hisada M, El-Omar EM. Helicobacter pylori associated global gastric cancer burden. Front Biosci (Landmark Ed). 2009;14:1490-1504. doi:10.2741/3320
    1. Fock KM, Ang TL. Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol. 2010;25(3):479-486. doi:10.1111/j.1440-1746.2009.06188.x
    1. Chan OO, Wong B. Risk factors for gastric cancer. Accessed March 15, 2021.
    1. Boeing H. Epidemiological research in stomach cancer: progress over the last ten years. J Cancer Res Clin Oncol. 1991;117(2):133-143. doi:10.1007/BF01613137
    1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans . Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum. 2004;83:1-1438.
    1. Yang P, Zhou Y, Chen B, et al. . Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Eur J Cancer. 2009;45(16):2867-2873. doi:10.1016/j.ejca.2009.04.019
    1. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986;8:1-27. doi:10.1093/oxfordjournals.epirev.a036288
    1. Rothenbacher D, Brenner H. Burden of Helicobacter pylori and H. pylori-related diseases in developed countries: recent developments and future implications. Microbes Infect. 2003;5(8):693-703. doi:10.1016/S1286-4579(03)00111-4
    1. WHO global report on trends in prevalence of tobacco smoking. Accessed March 25, 2020.
    1. Hipgrave DB, Chang S, Li X, Wu Y. Salt and sodium intake in China. JAMA. 2016;315(7):703-705. doi:10.1001/jama.2015.15816
    1. Inoue M. Changing epidemiology of Helicobacter pylori in Japan. Gastric Cancer. 2017;20(suppl 1):3-7. doi:10.1007/s10120-016-0658-5
    1. Shimazu T, Wakai K, Tamakoshi A, et al. ; Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan . Association of vegetable and fruit intake with gastric cancer risk among Japanese: a pooled analysis of four cohort studies. Ann Oncol. 2014;25(6):1228-1233. doi:10.1093/annonc/mdu115
    1. Lagergren F, Xie SH, Mattsson F, Lagergren J. Updated incidence trends in cardia and non-cardia gastric adenocarcinoma in Sweden. Acta Oncol. 2018;57(9):1173-1178. doi:10.1080/0284186X.2018.1457797
    1. Cavatorta O, Scida S, Miraglia C, et al. . Epidemiology of gastric cancer and risk factors. Acta Biomed. 2018;89(8 suppl):82-87. doi:10.23750/abm.v89i8-S.7966
    1. Milne AN, Offerhaus GJ. Early-onset gastric cancer: learning lessons from the young. World J Gastrointest Oncol. 2010;2(2):59-64. doi:10.4251/wjgo.v2.i2.59
    1. Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M. Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism. 2019;92:121-135. doi:10.1016/j.metabol.2018.11.001
    1. World Health Organization . Obesity and overweight. Accessed March 22, 2020.
    1. Wong MCS, Huang J, Wang J, et al. . Global, regional and time-trend prevalence of central obesity: a systematic review and meta-analysis of 13.2 million subjects. Eur J Epidemiol. 2020;35(7):673-683. doi:10.1007/s10654-020-00650-3
    1. Berger NA. Young adult cancer: influence of the obesity pandemic. Obesity (Silver Spring). 2018;26(4):641-650. doi:10.1002/oby.22137
    1. Xie F, Wang D, Huang Z, Guo Y. Coffee consumption and risk of gastric cancer: a large updated meta-analysis of prospective studies. Nutrients. 2014;6(9):3734-3746. doi:10.3390/nu6093734
    1. National Coffee Association . The 67th National Coffee Drinking Trends Report of the US. Updated 2021. Accessed March 22, 2020.
    1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90. doi:10.3322/caac.20107

Source: PubMed

3
Suscribir